{"organizations": [], "uuid": "1bb7742bfeeb4d80e52534dd0795498dbe354855", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cancer-genetics-reports-q4-loss-pe/brief-cancer-genetics-reports-q4-loss-per-share-of-0-35-idUSASC09UJ0", "country": "US", "domain_rank": 408, "title": "BRIEF-Cancer Genetics Reports Q4 Loss Per Share Of $0.35", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-02T23:12:00.000+03:00", "replies_count": 0, "uuid": "1bb7742bfeeb4d80e52534dd0795498dbe354855"}, "author": "", "url": "https://www.reuters.com/article/brief-cancer-genetics-reports-q4-loss-pe/brief-cancer-genetics-reports-q4-loss-per-share-of-0-35-idUSASC09UJ0", "ord_in_thread": 0, "title": "BRIEF-Cancer Genetics Reports Q4 Loss Per Share Of $0.35", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "raymond james & associates inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 2, 2018 / 8:15 PM / in 7 minutes BRIEF-Cancer Genetics Reports Q4 Loss Per Share Of $0.35 Reuters Staff 1 Min Read \nApril 2 (Reuters) - Cancer Genetics Inc: \n* CANCER GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES STRATEGIC BUSINESS UPDATES * Q4 REVENUE $7.5 MILLION VERSUS I/B/E/S VIEW $9.2 MILLION \n* Q4 EARNINGS PER SHARE VIEW $-0.11 — THOMSON REUTERS I/B/E/S \n* HAS UNDERTAKEN A “COMPREHENSIVE AND EXTENSIVE” REVIEW OF ITS STRATEGY AND ORGANIZATION \n* ENGAGED RAYMOND JAMES & ASSOCIATES INC AS A FINANCIAL ADVISOR TO ASSIST WITH EVALUATING OPTIONS FOR COMPANY’S STRATEGIC DIRECTION \n* OPTIONS FOR CO’S STRATEGIC DIRECTION MAY INCLUDE RAISING ADDITIONAL CAPITAL, ACQUISITION OF ANOTHER COMPANY OR SALE OF THE COMPANY Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-02T23:12:00.000+03:00", "crawled": "2018-04-02T23:28:59.002+03:00", "highlightTitle": ""}